Request Webinar Form

Webinar: ALDH+ Cancer Precursor Cells in Drug Response Prediction

Mr. Ed Field, Chief Operating Officer at Aldagen, explains the principles behind ALDEFLUOR™-based detection of ALDH bright cells and discusses evidence demonstrating ALDH’s potential as a biomarker for cancer stem cell characterization and tumor prognosis.

To view the webinar, please complete the form, or sign in to your account.

I agree to receive future electronic communications from STEMCELL. I acknowledge that I can unsubscribe any time.

By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.